OBJ Limited (ASX: OBJ) is pleased to announce the signing of an...

OBJ Limited (ASX: OBJ) is pleased to announce the signing of an Evaluation Agreement
with GlaxoSmithKline Consumer Healthcare (GSK). GSK has granted permission to the
Company to release the following statement:
OBJ Limited wishes to advise that it has entered into a short term evaluation
agreement with GlaxoSmithKline Consumer Healthcare (GSK).
The Evaluation Agreement involves an evaluation of OBJs ETP technology in a
non‐prescription consumer healthcare application.
OBJ and GSK have worked together on three previous occasions and the current
Agreement is a continuation of that relationship.